z-logo
open-access-imgOpen Access
Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts
Author(s) -
Florian Perner,
Jayant Y. Gadrey,
Yijun Xiong,
Charlie Hatton,
Benjamin K. Eschle,
Andreas Weiss,
Frédéric Stauffer,
Christoph Gaul,
Ralph Tiedt,
Jennifer A. Perry,
Scott A. Armstrong,
Andrei V. Krivtsov
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020006113
Subject(s) - methyltransferase , cancer research , histone , histone methyltransferase , pharmacology , medicine , chemistry , biology , genetics , methylation , dna

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom